Measuring effectiveness.
暂无分享,去创建一个
[1] Gordon H Guyatt,et al. How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches. , 2013, Journal of evaluation in clinical practice.
[2] J. Fuller. Rationality and the generalization of randomized controlled trial evidence. , 2013, Journal of evaluation in clinical practice.
[3] Paul Teller. The concept of measurement-precision , 2012, Synthese.
[4] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[5] J. Kragstrup,et al. Danish GPs' perception of disease risk and benefit of prevention. , 2002, Family practice.
[6] J. Stegenga. Effectiveness of medical interventions. , 2015, Studies in history and philosophy of biological and biomedical sciences.
[7] Jesper Nielsen,et al. Laypersons' understanding of relative risk reductions: Randomised cross-sectional study , 2008, BMC Medical Informatics Decis. Mak..
[8] C D Naylor,et al. Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness? , 1992, Annals of Internal Medicine.
[9] J. Dupré. Across the Boundaries: Extrapolation in Biology and Social Science , 2010 .
[10] J. Swanson,et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[11] Ines Fischer,et al. Scientific Representation: Paradoxes of Perspective , 2009 .
[12] B. Demichelis,et al. Completeness of reporting trial results: effect on physicians' willingness to prescribe , 1994, The Lancet.
[13] Eran Tal. How Accurate Is the Standard Second? , 2011, Philosophy of Science.
[14] Martin Schweitzer,et al. Measuring the success of public participation on environmental restoration and waste management activities in the U.S. Department of Energy , 1998 .
[15] Eric M. Meslin,et al. The Ethics of Information: Absolute Risk Reduction and Patient Understanding of Screening , 2008, Journal of General Internal Medicine.
[16] N. Hadler. Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer , 2007 .
[17] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[18] Leah McClimans. The role of measurement in establishing evidence. , 2013, The Journal of medicine and philosophy.
[19] D. Moher,et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[20] Robert D Gibbons,et al. 3-year follow-up of the NIMH MTA study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[21] Eran Tal,et al. Making Time: A Study in the Epistemology of Measurement , 2016, The British Journal for the Philosophy of Science.
[22] M. Susser,et al. Philosophy in epidemiology , 1991, Theoretical medicine.
[23] Jacob Stegenga,et al. Is meta-analysis the platinum standard of evidence? , 2011, Studies in history and philosophy of biological and biomedical sciences.
[24] J. Howick. Exposing the Vanities—and a Qualified Defense—of Mechanistic Reasoning in Health Care Decision Making , 2011, Philosophy of Science.
[25] M Egger,et al. The causes and effects of socio-demographic exclusions from clinical trials. , 2005, Health technology assessment.
[26] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[27] R M Arnold,et al. Absolutely relative: how research results are summarized can affect treatment decisions. , 1992, The American journal of medicine.
[28] Nancy Cartwright. Evidence, external validity and explanatory relevance. , 2011 .
[29] A. Alexandrova. First-Person Reports and the Measurement of Happiness , 2008 .
[30] R. Kuhn,et al. International Studies in the Philosophy of Science , 2009 .
[31] Michael G. Samarkos,et al. The philosophy of Evidence-based Medicine , 2006 .
[32] Jon Williamson,et al. Interpreting Causality in the Health Sciences , 2007 .
[33] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[34] Leah McClimans. A theoretical framework for patient-reported outcome measures , 2010, Theoretical medicine and bioethics.
[35] A. Waldman,et al. Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials , 2014, Multiple sclerosis international.
[36] J. Avorn,et al. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. , 1992, JAMA.
[37] D. Eyding,et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials , 2010, BMJ : British Medical Journal.
[38] J. Worrall. Do We Need Some Large, Simple Randomized Trials in Medicine? , 2010 .
[39] Phyllis Illari,et al. Mechanistic Evidence: Disambiguating the Russo–Williamson Thesis , 2011 .
[40] Jacob Stegenga,et al. Probabilizing the end , 2013 .